EP3265454
TGF-BETA INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.2.2016EP published:
26.2.2020EP application number:
16710547.7
EPO information:
European Patent Register
Max expiry date:
25.2.2036
Title:
TGF-BETA INHIBITORS
Timeline
Today
26.2.2016EP application
26.2.2020EP Publication
Owner
Name:
Rigel Pharmaceuticals, Inc.Address:
1180 Veterans Boulevard, South San Francisco, CA 94080, US
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
KINSELLA, ToddAddress:
Redwood City, CA 94061, US
Name:
GELMAN, MarinaAddress:
San Francisco, CA 94121, US
Name:
HONG, HuiAddress:
Foster City, CA 94404, US
Name:
DARWISH, Ihab, S.Address:
San Carlos, CA 94070, US
Name:
SINGH, RajinderAddress:
Belmont, CA 94002, US
Name:
YU, JiaxinAddress:
San Carlos, CA 94070, US
Name:
BORZILLERI, Robert, M.Address:
Princeton, NJ 08543, US
Name:
VELAPARTHI, UpenderAddress:
Wallingford, CT 06492, US
Name:
LIU, PeiyingAddress:
Wallingford CT 06492, US
Name:
DARNE, ChetanAddress:
Wallingford, CT 06492, US
Name:
RAHAMAN, HasiburAddress:
Bangalore 560100, IN
Name:
WARRIER, Jayakumar, SankaraAddress:
Bangalore 560068, IN
Priority
Number:
201562127109 PDate:
2.3.2015Country:
US
Classification
Categories:
C07D 401/04, C07D 403/04, C07D 417/04, C07D 471/04, C07D 487/04, A61K 31/4164, A61K 31/426, A61P 35/00